13 reports of this reaction
1.6% of all HYDROGEN PEROXIDE reports
#11 most reported adverse reaction
GASTRITIS EROSIVE is the #11 most commonly reported adverse reaction for HYDROGEN PEROXIDE, manufactured by Rowpar Pharmaceuticals, Inc.. There are 13 FDA adverse event reports linking HYDROGEN PEROXIDE to GASTRITIS EROSIVE. This represents approximately 1.6% of all 808 adverse event reports for this drug.
Patients taking HYDROGEN PEROXIDE who experience gastritis erosive should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GASTRITIS EROSIVE is a less commonly reported adverse event for HYDROGEN PEROXIDE, but still significant enough to appear in the safety profile.
In addition to gastritis erosive, the following adverse reactions have been reported for HYDROGEN PEROXIDE:
GASTRITIS EROSIVE has been reported as an adverse event in 13 FDA reports for HYDROGEN PEROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
GASTRITIS EROSIVE accounts for approximately 1.6% of all adverse event reports for HYDROGEN PEROXIDE, making it a notable side effect.
If you experience gastritis erosive while taking HYDROGEN PEROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.